Oral Session 1-5B AML: Novel agents

[OS1-5B-1] Intracellular trafficking of mutated RTKs shows promising therapeutic target against AML

Shinya Rai¹, Hirokazu Tanaka¹, Mai Suzuki², Luis Espinoza¹, Akira Tanimura³, Yasuyoshi Morita^1,3, Yoichi Tatsumi¹, Takafumi Yokota³, Kenji Oritani⁴, Toshio Watanabe⁵, Yuzuru Kanakura³, Itaru Matsumura¹ (1.Hematol and Rheumatol, Kindai Univ, Osaka,Japan, 2.Hematol, National Cancer Center Research Institute, Tokyo Japan, 3.Hematol and Oncol, Osaka Univ, Osaka, Japan, 4.Hematol, International Univ of Health and Welfare, Chiba, Japan, 5.Biological Science, Humanities and Sciences, Nara Women's Univ, Nara, Japan)